| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/19/2002 | EP1214349A2 Secreted soluble alpha2delta-2, alpha2delta-3 or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 06/19/2002 | EP1214340A2 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214098A1 Capsid-modified recombinant adenovirus and methods of use |
| 06/19/2002 | EP1214097A1 Nucleic acids encoding polyepitope polypeptides |
| 06/19/2002 | EP1214091A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214088A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 06/19/2002 | EP1214082A2 Methods and compositions for reducing immune response |
| 06/19/2002 | EP1214074A2 Dioxolane nucleoside analogs for the treatment or prevention of viral infection |
| 06/19/2002 | EP0900275B1 Methods and reagents for modulating apoptosis |
| 06/19/2002 | EP0879062B1 Nucleic acid delivery vehicle |
| 06/19/2002 | EP0625204B1 Hepatitis therapeutics |
| 06/19/2002 | CN1354800A Recombinant newcastle disease virus RNA expression systems and vaccines |
| 06/19/2002 | CN1354796A Medical preparations for treatment of alpha-galactosidase A deficiency |
| 06/19/2002 | CN1354791A Compositions for treatment and diagnosis of breast cancer and methods for their use |
| 06/19/2002 | CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/19/2002 | CN1354678A Polyethyleneimine: DNA formulations for aerosol delivery |
| 06/19/2002 | CN1354671A Method for inhibition of phospholamban activity for treatment of cardiac disease and heart failure |
| 06/19/2002 | CN1354657A EGF-R antagonists for treating hypersecretion of mucus in lungs |
| 06/19/2002 | CN1354017A RIZ gene medicine composition and its application for curing cancer |
| 06/18/2002 | US6408051 Electromagnetic object detector provided with an additional electrode and intended for a medical radiation apparatus |
| 06/18/2002 | US6407204 Use of conantokins for producing analgesia or for neuoprotection |
| 06/18/2002 | US6407178 Complexing |
| 06/18/2002 | US6407062 Polypeptide; antiproliferative agent |
| 06/18/2002 | US6406911 Recombitant cells with reporter sequence for reporter gene and heterologous sequence which codes cd4 or other cell surface receptors regulated by a protein specific to hiv |
| 06/18/2002 | US6406888 Cytokines, transcription, dna segments and termination |
| 06/18/2002 | US6406861 Viral diseases and immunogens |
| 06/18/2002 | US6406852 Transporting biological material and bombardment of cells |
| 06/18/2002 | US6406704 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/13/2002 | WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 06/13/2002 | WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | WO2002046424A2 Fibroblast growth factors |
| 06/13/2002 | WO2002046419A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/13/2002 | WO2002046412A2 Regulation of angiogenesis with zinc finger proteins |
| 06/13/2002 | WO2002046403A2 Regulation of human patched-like protein |
| 06/13/2002 | WO2002046402A2 Regulation of human patched-like protein |
| 06/13/2002 | WO2002046401A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue |
| 06/13/2002 | WO2002046373A1 Method of collecting placental stem cells |
| 06/13/2002 | WO2002046367A2 Antisense modulation of cellular apoptosis susceptibility gene expression |
| 06/13/2002 | WO2002046364A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 06/13/2002 | WO2002046225A2 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 06/13/2002 | WO2002046224A2 Compositions and methods relating to lung specific genes and proteins |
| 06/13/2002 | WO2002046223A2 Compositions and methods related to the minn1 tumor suppressor gene and protein |
| 06/13/2002 | WO2002046220A2 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 06/13/2002 | WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | WO2002045755A2 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma |
| 06/13/2002 | WO2002045744A1 Spliced gene of kshv/hhv8, its promoter and monoclonal antibodies specific for lana2 |
| 06/13/2002 | WO2002045739A1 Immunomodulatory constructs and their uses |
| 06/13/2002 | WO2002045737A2 Methods of treatment involving human mda-7 |
| 06/13/2002 | WO2002045708A2 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 06/13/2002 | WO2002045652A2 Tyrosine kinase inhibitors |
| 06/13/2002 | WO2002022663A3 Stress resistant retroviruses |
| 06/13/2002 | WO2002020038A3 Method for down-regulating ige |
| 06/13/2002 | WO2002014357A3 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage |
| 06/13/2002 | WO2002008263A3 Modified virus having an altered tropism |
| 06/13/2002 | WO2001098350A3 Compositions comprising net-4 modulations and their use for treating neoplastic disease |
| 06/13/2002 | WO2001096377A3 Vaccine for congenital tremors in pigs |
| 06/13/2002 | WO2001092294A3 Therapeutic anti-melanoma compounds |
| 06/13/2002 | WO2001090159A3 Compositions and methods for delivery of a molecule into a cell |
| 06/13/2002 | WO2001089554A3 Treatment of acute coronary syndrome with glp-1 |
| 06/13/2002 | WO2001072843A3 Regulation of human c-myb-related genes |
| 06/13/2002 | WO2001072277A3 Immunotherapeutic methods and compositions |
| 06/13/2002 | WO2001068828A3 Compositions and methods for regulated protein expression in gut |
| 06/13/2002 | WO2001059103A3 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 06/13/2002 | WO2001042461A3 Apoptin-associating protein |
| 06/13/2002 | WO2000077262A9 Synthetic ligation reassembly in directed evolution |
| 06/13/2002 | WO2000066741A3 Conserved neisserial antigens |
| 06/13/2002 | WO2000064400A9 Methods for treating congestive heart failure |
| 06/13/2002 | WO2000061736A9 Recombinant and mutant marek's disease virus |
| 06/13/2002 | US20020072596 Nucleotide sequences coding transrerrins; for use in the treatment of nervous system., blood abbd anemia, heme biosynthesis disorders |
| 06/13/2002 | US20020072592 Nucleotide sequences which code anticarcinogenic agent for use in the treatment mammary gland cancer |
| 06/13/2002 | US20020072504 Method and reagents for genetic immunization |
| 06/13/2002 | US20020072494 Angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5) genetically engineered so it can be secreted from cells in which it is expressed; contains a secretory signal peptide and a pre-activation peptide derived from plasminogen |
| 06/13/2002 | US20020072493 To promote nerve regeneration or to confer neuroprotection by administering the T cells or a nervous system-specific antigen such as myelin basic protein |
| 06/13/2002 | US20020072120 Helper viruses for the preparation of recombinant viral vectors |
| 06/13/2002 | US20020072107 Human osteoclast derived cathepsin |
| 06/13/2002 | US20020072090 Hr-1 receptor |
| 06/13/2002 | US20020072066 Human osteoporosis gene |
| 06/13/2002 | US20020071849 A41L protein or a chemokine-binding fragment thereof; detecting an interaction of the chemokine-binding molecule with a chemokine; antiinflammatory agents |
| 06/13/2002 | US20020071834 Augmentation of wound healing by EIF4E mRNA and EGF mRNA |
| 06/13/2002 | US20020071833 Hematopoietic stem cell gene therapy |
| 06/13/2002 | US20020071832 Use of mutant herpes viruses and anticancer agents in the treatment of cancer |
| 06/13/2002 | US20020071831 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/13/2002 | US20020071829 Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| 06/13/2002 | US20020071828 Biocompatible cuff into which a system for expressing a neurotrophic factor is introduced. |
| 06/13/2002 | US20020071824 Gene transfer to pancreatic b cells for prevention of islet dysfunction |
| 06/13/2002 | DE10061334A1 Verwendung von aus embryonalen Stammzellen hergeleiteten Zellen zur Erhöhung der Transplantationstoleranz und zur Wiederherstellung zerstörten Gewebes Using derived from embryonic stem cells to increase transplant tolerance and restore damaged tissue |
| 06/13/2002 | CA2678490A1 Isolated placental perfusate and placental cells isolated therefrom |
| 06/13/2002 | CA2436856A1 Immunomodulatory constructs and their uses |
| 06/13/2002 | CA2436666A1 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 06/13/2002 | CA2431861A1 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 06/13/2002 | CA2431585A1 Compositions and methods related to the minn1 tumor suppressor gene and protein |
| 06/13/2002 | CA2431374A1 Novel fibroblast growth factors |
| 06/13/2002 | CA2431193A1 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 06/13/2002 | CA2430998A1 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma |
| 06/13/2002 | CA2430989A1 Method of collecting placental stem cells |
| 06/13/2002 | CA2430716A1 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | CA2430379A1 Endogenous retroviruses up-regulated in prostate cancer |